BPAMU
ABBV icon

BTG Pactual Asset Management US’s AbbVie ABBV Stock Holding History

BTG Pactual Asset Management US’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.15M Sell
28,406
-70
-0.2% -$15.1K 0.44% 60
2026
Q1 		$6.19M Buy
28,476
+5,598
+24% +$1.24M 0.54% 55
2025
Q4 		$5.23M Sell
22,878
-784
-3% -$179K 0.51% 51
2025
Q3 		$5.48M Buy
23,662
+13,439
+131% +$2.74M 0.26% 51
2025
Q2 		$1.9M Buy
10,223
+385
+4% +$71.6K 0.21% 94
2025
Q1 		$2.06M Buy
9,838
+2,035
+26% +$396K 0.22% 100
2024
Q4 		$1.36M Sell
7,803
-469
-6% -$86.2K 0.14% 129
2024
Q3 		$1.63M Buy
+8,272
New +$1.54M 0.14% 128

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BTG Pactual Asset Management US's ABBV Position: Q2 2026 in Review

BTG Pactual Asset Management US reduced its AbbVie (ABBV) stake by 0.25% in Q2 2026, selling an estimated $15.1K and leaving 28,406 shares worth $7.15M. The position accounts for 0.44% of the portfolio, ranked #60.

BTG Pactual Asset Management US first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,218 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • BTG Pactual Asset Management US held 28,406 shares of AbbVie worth $7.15M as of Q2 2026.
  • BTG Pactual Asset Management US sold 70 AbbVie shares in Q2 2026, an estimated $15.1K.
  • AbbVie made up 0.44% of BTG Pactual Asset Management US's portfolio in Q2 2026, its #60 holding.
  • BTG Pactual Asset Management US first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 4,218 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BTG Pactual Asset Management US's 13F filing for Q2 2026, filed 14 Aug 2026.